サマリー

世界のファージ療法市場 2024-2028
ファージ療法市場は2023-2028年に5100万米ドル成長し、予測期間中のCAGRは17.41%で加速すると予測される。この調査レポートは、ファージ療法市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、抗生物質に対するファージ療法の利点、動物の健康に対するファージ療法の応用の増加、ヒトの健康に対するファージ療法の応用の増加が牽引しています。
Technavioのファージ療法市場は以下のように区分される：
製品別
- 大腸菌
- 黄色ブドウ球菌
- サルモネラ菌
- その他
用途別
- 動物衛生
- 食品産業
- その他
地域別
- ヨーロッパ
- 北米
- アジア
- その他の地域（ROW）
本調査では、今後数年間のファージ療法市場の成長を促進する主な要因の1つとして、ファージ療法への投資の増加を挙げています。また、ファージ療法の臨床試験の増加やベンダー間のパートナーシップの増加は、市場の大きな需要につながる。
本レポートでは、ファージ療法市場について以下の領域をカバーしています：
- ファージ療法市場のサイジング
- ファージ療法市場予測
- ファージ療法市場の産業分析
本レポートでは、Adaptive Phage Therapeutics、APS Biocontrol Ltd.、Armata Pharmaceuticals Inc.、Astellas Pharma Inc、BiomX Inc.、CJ CheilJedang Corp.、Cytophage Technologies Inc.、Eliava Biopreparation LLC、Intralytix Inc.、iNtRON Biotechnology Inc.、JSC NPO Microgen、Locus Biosciences Inc.、Micreos、Micromir、Nexabiome、Proteon Pharmaceuticals S.A.、Taconic Biosciences Inc.、TechnoPhage、ZeptoMetrix LLC、Vitalis Wellness LLP。また、ファージ療法市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/phage-therapy-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global phage therapy market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global phage therapy market 2018 - 2022 ($ million)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.3 Application Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Escherichia coli - Market size and forecast 2023-2028
o Exhibit 34: Chart on Escherichia coli - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Escherichia coli - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Escherichia coli - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Escherichia coli - Year-over-year growth 2023-2028 (%)
o 6.4 Staphylococcus aureus - Market size and forecast 2023-2028
o Exhibit 38: Chart on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
o 6.5 Salmonella - Market size and forecast 2023-2028
o Exhibit 42: Chart on Salmonella - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Salmonella - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Salmonella - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Salmonella - Year-over-year growth 2023-2028 (%)
o 6.6 Others - Market size and forecast 2023-2028
o Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Product
o Exhibit 50: Market opportunity by Product ($ million)
o Exhibit 51: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 52: Chart on Application - Market share 2023-2028 (%)
o Exhibit 53: Data Table on Application - Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 54: Chart on Comparison by Application
o Exhibit 55: Data Table on Comparison by Application
o 7.3 Animal health - Market size and forecast 2023-2028
o Exhibit 56: Chart on Animal health - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Animal health - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Animal health - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Animal health - Year-over-year growth 2023-2028 (%)
o 7.4 Food industry - Market size and forecast 2023-2028
o Exhibit 60: Chart on Food industry - Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Food industry - Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Food industry - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Food industry - Year-over-year growth 2023-2028 (%)
o 7.5 Aquaculture and others - Market size and forecast 2023-2028
o Exhibit 64: Chart on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Data Table on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
o Exhibit 66: Chart on Aquaculture and others - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Aquaculture and others - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Application
o Exhibit 68: Market opportunity by Application ($ million)
o Exhibit 69: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.4 North America - Market size and forecast 2023-2028
o Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 Poland - Market size and forecast 2023-2028
o Exhibit 99: Chart on Poland - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Poland - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Poland - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Poland - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 UK - Market size and forecast 2023-2028
o Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Adaptive Phage Therapeutics
o Exhibit 119: Adaptive Phage Therapeutics - Overview
o Exhibit 120: Adaptive Phage Therapeutics - Product / Service
o Exhibit 121: Adaptive Phage Therapeutics - Key offerings
o 12.4 APS Biocontrol Ltd.
o Exhibit 122: APS Biocontrol Ltd. - Overview
o Exhibit 123: APS Biocontrol Ltd. - Product / Service
o Exhibit 124: APS Biocontrol Ltd. - Key offerings
o 12.5 Armata Pharmaceuticals Inc.
o Exhibit 125: Armata Pharmaceuticals Inc. - Overview
o Exhibit 126: Armata Pharmaceuticals Inc. - Product / Service
o Exhibit 127: Armata Pharmaceuticals Inc. - Key offerings
o 12.6 CJ CheilJedang Corp.
o Exhibit 128: CJ CheilJedang Corp. - Overview
o Exhibit 129: CJ CheilJedang Corp. - Business segments
o Exhibit 130: CJ CheilJedang Corp. - Key offerings
o Exhibit 131: CJ CheilJedang Corp. - Segment focus
o 12.7 Cytophage Technologies Inc.
o Exhibit 132: Cytophage Technologies Inc. - Overview
o Exhibit 133: Cytophage Technologies Inc. - Product / Service
o Exhibit 134: Cytophage Technologies Inc. - Key offerings
o 12.8 Intralytix Inc.
o Exhibit 135: Intralytix Inc. - Overview
o Exhibit 136: Intralytix Inc. - Product / Service
o Exhibit 137: Intralytix Inc. - Key offerings
o 12.9 iNtRON Biotechnology Inc.
o Exhibit 138: iNtRON Biotechnology Inc. - Overview
o Exhibit 139: iNtRON Biotechnology Inc. - Product / Service
o Exhibit 140: iNtRON Biotechnology Inc. - Key offerings
o 12.10 JSC NPO Microgen
o Exhibit 141: JSC NPO Microgen - Overview
o Exhibit 142: JSC NPO Microgen - Product / Service
o Exhibit 143: JSC NPO Microgen - Key offerings
o 12.11 Locus Biosciences Inc.
o Exhibit 144: Locus Biosciences Inc. - Overview
o Exhibit 145: Locus Biosciences Inc. - Product / Service
o Exhibit 146: Locus Biosciences Inc. - Key offerings
o 12.12 Micreos
o Exhibit 147: Micreos - Overview
o Exhibit 148: Micreos - Product / Service
o Exhibit 149: Micreos - Key offerings
o 12.13 Micromir
o Exhibit 150: Micromir - Overview
o Exhibit 151: Micromir - Product / Service
o Exhibit 152: Micromir - Key offerings
o 12.14 Nexabiome
o Exhibit 153: Nexabiome - Overview
o Exhibit 154: Nexabiome - Product / Service
o Exhibit 155: Nexabiome - Key offerings
o 12.15 Proteon Pharmaceuticals S.A.
o Exhibit 156: Proteon Pharmaceuticals S.A. - Overview
o Exhibit 157: Proteon Pharmaceuticals S.A. - Product / Service
o Exhibit 158: Proteon Pharmaceuticals S.A. - Key offerings
o 12.16 TechnoPhage
o Exhibit 159: TechnoPhage - Overview
o Exhibit 160: TechnoPhage - Product / Service
o Exhibit 161: TechnoPhage - Key offerings
o 12.17 ZeptoMetrix LLC
o Exhibit 162: ZeptoMetrix LLC - Overview
o Exhibit 163: ZeptoMetrix LLC - Product / Service
o Exhibit 164: ZeptoMetrix LLC - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global phage therapy market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Escherichia coli - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Escherichia coli - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Escherichia coli - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Escherichia coli - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Salmonella - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Salmonella - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Salmonella - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Salmonella - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Product ($ million)
Exhibits51: Data Table on Market opportunity by Product ($ million)
Exhibits52: Chart on Application - Market share 2023-2028 (%)
Exhibits53: Data Table on Application - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Application
Exhibits55: Data Table on Comparison by Application
Exhibits56: Chart on Animal health - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Animal health - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Animal health - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Animal health - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Food industry - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Food industry - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Food industry - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Food industry - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Aquaculture and others - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Aquaculture and others - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Application ($ million)
Exhibits69: Data Table on Market opportunity by Application ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Poland - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Poland - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Poland - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Poland - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Adaptive Phage Therapeutics - Overview
Exhibits120: Adaptive Phage Therapeutics - Product / Service
Exhibits121: Adaptive Phage Therapeutics - Key offerings
Exhibits122: APS Biocontrol Ltd. - Overview
Exhibits123: APS Biocontrol Ltd. - Product / Service
Exhibits124: APS Biocontrol Ltd. - Key offerings
Exhibits125: Armata Pharmaceuticals Inc. - Overview
Exhibits126: Armata Pharmaceuticals Inc. - Product / Service
Exhibits127: Armata Pharmaceuticals Inc. - Key offerings
Exhibits128: CJ CheilJedang Corp. - Overview
Exhibits129: CJ CheilJedang Corp. - Business segments
Exhibits130: CJ CheilJedang Corp. - Key offerings
Exhibits131: CJ CheilJedang Corp. - Segment focus
Exhibits132: Cytophage Technologies Inc. - Overview
Exhibits133: Cytophage Technologies Inc. - Product / Service
Exhibits134: Cytophage Technologies Inc. - Key offerings
Exhibits135: Intralytix Inc. - Overview
Exhibits136: Intralytix Inc. - Product / Service
Exhibits137: Intralytix Inc. - Key offerings
Exhibits138: iNtRON Biotechnology Inc. - Overview
Exhibits139: iNtRON Biotechnology Inc. - Product / Service
Exhibits140: iNtRON Biotechnology Inc. - Key offerings
Exhibits141: JSC NPO Microgen - Overview
Exhibits142: JSC NPO Microgen - Product / Service
Exhibits143: JSC NPO Microgen - Key offerings
Exhibits144: Locus Biosciences Inc. - Overview
Exhibits145: Locus Biosciences Inc. - Product / Service
Exhibits146: Locus Biosciences Inc. - Key offerings
Exhibits147: Micreos - Overview
Exhibits148: Micreos - Product / Service
Exhibits149: Micreos - Key offerings
Exhibits150: Micromir - Overview
Exhibits151: Micromir - Product / Service
Exhibits152: Micromir - Key offerings
Exhibits153: Nexabiome - Overview
Exhibits154: Nexabiome - Product / Service
Exhibits155: Nexabiome - Key offerings
Exhibits156: Proteon Pharmaceuticals S.A. - Overview
Exhibits157: Proteon Pharmaceuticals S.A. - Product / Service
Exhibits158: Proteon Pharmaceuticals S.A. - Key offerings
Exhibits159: TechnoPhage - Overview
Exhibits160: TechnoPhage - Product / Service
Exhibits161: TechnoPhage - Key offerings
Exhibits162: ZeptoMetrix LLC - Overview
Exhibits163: ZeptoMetrix LLC - Product / Service
Exhibits164: ZeptoMetrix LLC - Key offerings
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations